This expert-led webinar presented by Paul Monk, MD, discusses the importance of identifying hereditary cancer risk mutations for prostate cancer. Dr. Monk discusses prostate cancer treatment and trials, as well as screening for men with hereditary prostate cancer risk.
Dr. Paul Monk is a medical oncologist and an Associate Professor in the Department of Internal Medicine at The Ohio State University Comprehensive Cancer Center. Dr. Monk specializes in genitourinary cancers, which include cancers of the prostate, bladder, kidneys, and testicles.